Log in to save to my catalogue

A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine,...

A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine,...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2306222834

A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation

About this item

Full title

A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation

Publisher

London: Nature Publishing Group UK

Journal title

Bone marrow transplantation (Basingstoke), 2020-04, Vol.55 (4), p.804-810

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In this multicenter Phase 2 single arm study, we substituted low dose total body irradiation (TBI) for antithymocyte globulin (ATG) in a reduced intensity conditioning regimen with the intent to lower the risk for viral infections after double umbilical cord blood (UCB) transplantation. The conditioning regimen consisted of fludarabine (30 mg/m
...

Alternative Titles

Full title

A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2306222834

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2306222834

Other Identifiers

ISSN

0268-3369

E-ISSN

1476-5365

DOI

10.1038/s41409-019-0715-x

How to access this item